Rim M - Search Results

1

Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src.

Qureshi SA, Alexandropoulos K, Rim M, Joseph CK, Bruder JT, Rapp UR, Foster DA. Qureshi SA, et al. Among authors: rim m. J Biol Chem. 1992 Sep 5;267(25):17635-9. J Biol Chem. 1992. PMID: 1325443 Free article.

2

Sustained induction of egr-1 by v-src correlates with a lack of fos-mediated repression of the egr-1 promoter.

Qureshi SA, Rim MH, Alexandropoulos K, Berg K, Sukhatme VP, Foster DA. Qureshi SA, et al. Among authors: rim mh. Oncogene. 1992 Jan;7(1):121-5. Oncogene. 1992. PMID: 1741159

3

Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements.

Rim M, Qureshi SA, Gius D, Nho J, Sukhatme VP, Foster DA. Rim M, et al. Oncogene. 1992 Oct;7(10):2065-8. Oncogene. 1992. PMID: 1408148

4

v-Fps-responsiveness in the Egr-1 promoter is mediated by serum response elements.

Alexandropoulos K, Qureshi SA, Rim M, Sukhatme VP, Foster DA. Alexandropoulos K, et al. Among authors: rim m. Nucleic Acids Res. 1992 May 11;20(9):2355-9. doi: 10.1093/nar/20.9.2355. Nucleic Acids Res. 1992. PMID: 1594452 Free PMC article.

5

An inhibitory mutant of c-Raf-1 blocks v-Src-induced activation of the Egr-1 promoter.

Qureshi SA, Rim M, Bruder J, Kolch W, Rapp U, Sukhatme VP, Foster DA. Qureshi SA, et al. Among authors: rim m. J Biol Chem. 1991 Nov 5;266(31):20594-7. J Biol Chem. 1991. PMID: 1939108 Free article.

6

v-Src activates both protein kinase C-dependent and independent signaling pathways in murine fibroblasts.

Qureshi SA, Joseph CK, Rim M, Maroney A, Foster DA. Qureshi SA, et al. Among authors: rim m. Oncogene. 1991 Jun;6(6):995-9. Oncogene. 1991. PMID: 2067850

7

Zwitterion Interlocked Diarylethene Molecules Order, Unconnected Diarylethene Molecules Disorder.

Wi Y, Kang DG, Ko H, Oh M, Jang J, Rim M, Lee KM, Godman NP, McConney ME, Jeong KU. Wi Y, et al. Among authors: rim m. Small. 2024 Dec 17:e2410466. doi: 10.1002/smll.202410466. Online ahead of print. Small. 2024. PMID: 39690865

8

Recent and anticipated novel drug approvals (4Q 2024 through 3Q 2025).

Rim MH, Dean C, Aliaj E, Dandino M, Tanriverdi T, Levitsky AM. Rim MH, et al. Am J Health Syst Pharm. 2024 Nov 23:zxae352. doi: 10.1093/ajhp/zxae352. Online ahead of print. Am J Health Syst Pharm. 2024. PMID: 39578227

9

Stretchable Heat Transfer Eco-Materials: Mesogen Grafted NR-Based Nanocomposites with High Thermal Conductivity and Low Dielectric Constant.

Hyeong J, Koo J, Rim M, Wi Y, Ko H, Yu D, Kim S, Kim N, Yoo MJ, Jeong KU. Hyeong J, et al. Among authors: rim m. Small. 2025 Jan;21(2):e2406066. doi: 10.1002/smll.202406066. Epub 2024 Sep 2. Small. 2025. PMID: 39221661

10

Recent and anticipated novel drug approvals (3Q 2024 through 2Q 2025).

Rim MH, Dean C, Aliaj E, Karas BL, Barada F, Levitsky AM. Rim MH, et al. Am J Health Syst Pharm. 2024 Nov 7;81(22):1103-1108. doi: 10.1093/ajhp/zxae242. Am J Health Syst Pharm. 2024. PMID: 39194065 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters